CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT01835041 · COMPLETED

Trial details

NCT number: NCT01835041
Sponsor: Wake Forest University Health Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2013-04-01
Primary completion: 2017-02-28
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.